| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.086 | 0.07 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.053 | 0.07 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.07 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |